THE PATHOPHYSIOLOGY OF SANDIMMUNE (CYCLOSPORINE) IN MAN AND ANIMALS

被引:107
作者
MASON, J
机构
[1] Preclinical and Clinical Research, Sandoz Pharma Ltd, Basle
关键词
RENAL TUBULAR FUNCTION; RENAL HEMODYNAMICS; RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM; PROSTAGLANDIN-THROMBOXANE SYSTEM; SYSTEMIC BLOOD VESSELS;
D O I
10.1007/BF00869843
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Part I: The side-effects of Sandimmune that have been of most significance clinically are renal dysfunction, renal vascular damage and arterial hypertension. To examine the nature and the origin of such effects, the actions of Sandimmune on the renal tubule, the renal vessels and systemic vessels have been analyzed. To evaluate whether common vasoconstrictory systems may be involved, changes in the renin-angiotensin-aldosterone system and prostaglandin-thromboxane system have been assessed. Comparison between animal and human data obtained in vivo and in vitro shows the actions of Sandimmune on the renal tubule to be modest and involve only a few specific effects. The major action of Sandimmune is on the vessels, vasoconstriction being the major cause of renal dysfunction and also the cause of arterial hypertension. Neither the circulating renin-angiotension-aldosterone system nor the prostaglandin-thromboxane system is clearly responsible for vasoconstriction. Although not itself a vasoconstrictor, Sandimmune seems to modulate the constrictory and dilatory response to other agents in several vascular beds.
引用
收藏
页码:554 / 574
页数:21
相关论文
共 170 条
[1]  
Farthing M.J.G., Clark M.L., Pendry A., Sloane J., Alexander P., Nature of the toxicity of cyclosporin A in the rat, Biochem Pharmacol, 30, pp. 3311-3316, (1981)
[2]  
Blair J.T., Thoon A.W., Whiting P.H., Davidson R.J.L., Simpson J.G., Toxicity of the immune suppressant cyclosporin A in the rat, J Pathol, 138, pp. 163-178, (1982)
[3]  
Bertani T., Perico N., Abbate M., Battaglia C., Remuzzi G., Renal injury induced by long-term administration of cyclosporin A to rats, Am J Pathol, 127, pp. 569-579, (1987)
[4]  
Gillum D.M., Truong L., Tasby J., Migliore P., Suki W.N., Chronic cyclosporine nephrotoxicity. A rodent model, Transplantation, 46, pp. 285-292, (1988)
[5]  
Mihatsch M.J., Ryffel B., Hermle M., Brunner F.P., Thiel G., Morphology of cyclosporine nephrotoxicity in the rat, Clin Nephrol, 25, pp. S2-S8, (1986)
[6]  
Whiting P.H., Propper D.J., Simpson J.G., McKay J., Jones M.C., Catto G.R.D., The use of lithium clearance measurements to assess renal tubular function in experimental and clinical cyclosporine nephrotoxicity, Transplant Proc, 20, pp. 675-680, (1988)
[7]  
Tejani A., Lancman I., Poantz A., Khawar M., Chen C., Nephrotoxicity of cyclosporine A and cyclosporine G in a rat model, Transplantation, 45, pp. 184-187, (1988)
[8]  
Teraoka S., Sanaka T., Takahashi K., Toma H., Yamaguchi Y., Yagisawa T., Tanabe K., Sato H., Matsumura O., Nakajima I., Kawai T., Honda H., Fuchinoue S., Agishi T., Ota K., Stimulation of intrinsic prostacyclin synthesis and inhibition of thromboxane production to minimize cyclosporine nephrotoxicity, Transplant Proc, 20, pp. 638-645, (1988)
[9]  
English J., Evan A., Houghton D.C., Bennett W.M., Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function, Transplantation, 44, pp. 135-141, (1987)
[10]  
Whiting P.H., Simpson J.G., Lithium clearance measurements as an indication of cyclosporin A nephrotoxicity in the rat, Clin Sci, 74, pp. 173-178, (1988)